On March 27, 2023, China’s National Medical Products Administration (NMPA) announced adjustments to its management policies on the submission of cosmetic ingredient safety information, relaxing some regulatory requirements. This move is in response to some enterprises experiencing difficulties in obtaining the necessary documents due to factors such as the COVID-19 pandemic related restrictions.
It is worth noting that upon the issuance of this announcement, in case of any inconsistency between this announcement and relevant documents on this topic previously released by NMPA, this announcement shall prevail.